Cargando…
The Use of Polymer Blends in the Treatment of Ocular Diseases
The eye is an organ with limited drug access due to its anatomical and physiological barriers, and the usual forms of ocular administration are limited in terms of drug penetration, residence time, and bioavailability, as well as low patient compliance. Hence, therapeutic innovations in new drug del...
Autores principales: | Arribada, Raquel Gregorio, Behar-Cohen, Francine, de Barros, Andre Luis Branco, Silva-Cunha, Armando |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322751/ https://www.ncbi.nlm.nih.gov/pubmed/35890326 http://dx.doi.org/10.3390/pharmaceutics14071431 |
Ejemplares similares
-
In Vitro and In Vivo Effect of pH-Sensitive PLGA-TPGS-Based Hybrid Nanoparticles Loaded with Doxorubicin for Breast Cancer Therapy
por: Fernandes, Renata S., et al.
Publicado: (2022) -
Chronic Systemic Dexamethasone Regulates the Mineralocorticoid/Glucocorticoid Pathways Balance in Rat Ocular Tissues
por: Zola, Marta, et al.
Publicado: (2022) -
Ocular Barriers and Their Influence on Gene Therapy Products Delivery
por: Leclercq, Bastien, et al.
Publicado: (2022) -
Evaluation of Ocular and Systemic Oxidative Stress Markers in Ocular Rosacea Patients
por: Yesilirmak, Nilufer, et al.
Publicado: (2023) -
High temperature polymer blends
por: DeMeuse, Mark T
Publicado: (2014)